Cite
HARVARD Citation
Tanaka, E. et al. (n.d.). AB0528 Cost-effectiveness of a humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, tocilizumab, in rheumatoid arthritis using IORRA cohort database. Annals of the rheumatic diseases. p. 668. [Online].